Kiel PJ - Search Results

1

Enasidenib: An Oral IDH2 Inhibitor for the Treatment of Acute Myeloid Leukemia.

Myers RA, Wirth S, Williams S, Kiel PJ. Myers RA, et al. Among authors: kiel pj. J Adv Pract Oncol. 2018 May-Jun;9(4):435-440. Epub 2018 May 1. J Adv Pract Oncol. 2018. PMID: 30719396 Free PMC article. Review.

2

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia.

Khawaja MR, Perkins SM, Schwartz JE, Robertson MJ, Kiel PJ, Sayar H, Cox EA, Vance GH, Farag SS, Cripe LD, Nelson RP Jr. Khawaja MR, et al. Among authors: kiel pj. Am J Hematol. 2015 Feb;90(2):97-9. doi: 10.1002/ajh.23875. Am J Hematol. 2015. PMID: 25345651 Free article.

3

Pharmacokinetics of Basiliximab for the Prevention of Graft-versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplantation with Minimal-Intensity Cyclophosphamide and Fludarabine.

Podichetty JT, Brinda BJ, Nelson RP, Karr AH, Prasad NK, Quinney S, Foxworthy Scott S, Kiel PJ. Podichetty JT, et al. Among authors: kiel pj. Pharmacotherapy. 2020 Jan;40(1):26-32. doi: 10.1002/phar.2347. Epub 2019 Dec 20. Pharmacotherapy. 2020. PMID: 31742732 Clinical Trial.

4

Incidence of venous thromboembolism in the setting of hematopoietic cell transplantation.

O'Hara VJ, Miller T, Mehta R, Swartzendruber E, Kiel PJ. O'Hara VJ, et al. Among authors: kiel pj. Am J Ther. 2014 Jan-Feb;21(1):15-9. doi: 10.1097/MJT.0b013e31829b59f5. Am J Ther. 2014. PMID: 24061558

5

Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.

Whited L, Grove M, Rose D, Rhodes NJ, Scheetz MH, O'Donnell JN, Neeb J, Thoele K, Jones DR, Lowe C, Moore D, Kiel PJ. Whited L, et al. Among authors: kiel pj. Pharmacotherapy. 2016 Sep;36(9):1003-10. doi: 10.1002/phar.1807. Epub 2016 Sep 6. Pharmacotherapy. 2016. PMID: 27496678

6

Sustained Exceptional Response to Poly (ADP-Ribose) Polymerase Inhibition Plus Temozolomide in Metastatic Melanoma With DNA Repair Deficiency.

Kiel PJ, Radovich M, Schneider BP, Logan TF. Kiel PJ, et al. JCO Precis Oncol. 2018 Nov;2:1-7. doi: 10.1200/PO.18.00150. JCO Precis Oncol. 2018. PMID: 35135169 No abstract available.

7

Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic.

Raheem F, Kim P, Grove M, Kiel PJ. Raheem F, et al. Among authors: kiel pj. Pharmacy (Basel). 2020 Mar 8;8(1):32. doi: 10.3390/pharmacy8010032. Pharmacy (Basel). 2020. PMID: 32182657 Free PMC article.

8

Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer Therapy.

Schneider BP, Stout LA, Philips S, Schroeder C, Scott SF, Hunter C, Kassem N, Kiel PJ, Radovich M. Schneider BP, et al. Among authors: kiel pj. JCO Precis Oncol. 2020 Nov;4:1109-1121. doi: 10.1200/PO.19.00354. JCO Precis Oncol. 2020. PMID: 35050776

9

Trimethoprim-sulfamethoxazole-induced rhabdomyolysis in an allogeneic stem cell transplant patient.

Kiel PJ, Dickmeyer N, Schwartz JE. Kiel PJ, et al. Transpl Infect Dis. 2010 Oct;12(5):451-4. doi: 10.1111/j.1399-3062.2010.00524.x. Transpl Infect Dis. 2010. PMID: 20561303

10

Impact of an Oral Antineoplastic Renewal Clinic on Medication Possession Ratio and Cost-Savings.

Crawford BS, Stauder AL, Bullington SM, Kiel PJ, Dark ER, Johnson JM, Zillich AJ. Crawford BS, et al. Among authors: kiel pj. Fed Pract. 2021 Mar;38(3):e8-e14. doi: 10.12788/fp.0107. Epub 2021 Mar 22. Fed Pract. 2021. PMID: 33859467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters